Jaya Lakshmi Thangaraj

Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells

Jaya Lakshmi Thangaraj, Michael Coffey, Edith Lopez et al. · Cell stem cell · 2024 · 53 citations · Full text

Effective Killing, Liver Physiology, Immunology +7

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung et al. · Cellular and Molecular Immunology · 2021 · 42 citations · Full text

Cancer Immunosurveillance, Antimyeloma Effect, Immunology +9

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon et al. · Cancer Immunology Immunotherapy · 2021 · 33 citations · Full text

Hematological Malignancy, Immunology, K562 Cells +10

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo et al. · Cancer Immunology Immunotherapy · 2022 · 21 citations · Full text

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Tan-Huy Chu, Manh-Cuong Vo, Jaya Lakshmi Thangaraj et al. · Translational Oncology · 2022 · 19 citations · Full text